Iantrek
Elkins Park, US · 5 known investors
Iantrek develops medical devices and technologies for micro-interventional ophthalmic surgery, specifically targeting glaucoma treatment through uveoscleral pathway outflow enhancement for surgeons and ophthalmologists.
Medical Devices
Investors · 5
In the news
- Iantrek Receives $30M in Growth Capital From Trinity Capitalfinsmes.com · 2026
- Trinity Capital commits $30M debt facility to Iantrek | TRIN Stock Newsstocktitan.net · 2026
- VM - Iantrek Raises $42 Million in Series C Funding to Launch Interventional Glaucoma Therapyvisionmonday.com · 2025
- Iantrek Raises $42 Million Series C to Launch AlloFlo – Visionary Venturesvisionaryvc.com · 2025
- Iantrek Raises $42M in Series C Fundingfinsmes.com · 2025
- Iantrek Raises $42 Million Series C to Launch AlloFlo™ Uveo, a Breakthrough Interventional Glaucoma Therapyglobenewswire.com · 2025